- Polymorphism Of Scn9a Gene Is More Frequent In Bladder Pain Syndrome /Interstitial Cystitis Biopsy Specimens And Associated With Higher Pain Scores
Mayer RD, Reeder JE
- Population pharmacokinetics of continuous infusion of factor VIII in hemophilia-A patients undergoing orthopedic surgery
Larger M, Bressolle F, Chevalier Y, Chamouard V, Negrier C, Boulieu R
- Population pharmacokinetics of levosulpiride with genetic polymorphisms of MDR1 gene in healthy subject
Cho HY, Lee YB
- Possible roles of aquaporins and fetuin-B in the preterm delivery in the rat
Ducza E, Seres A, Gaspar R, Falkay G
- Potential antipsoriatic effect of chondroitin sulphate by inhibition of NF-?B and STAT3 signalling pathways
Andres RM, Terencio MC, Paya M, Montesinos MC, Navalon P, Valcuende F, Herrero M, Verges J
- Potential of resveratrol in anticancer therapy
Demirtas T, Gacar G, Utkan T, Gacar N, Akpinar B, Karaoz E, Utkan Z
- PPARβ/δ activation prevents the high glucose-induced impairment of insulin stimulated nitric oxide production in human endothelial cells by reducing mitochondrial reactive oxygen species
Quintela AM, Jimenez R, Piqueras L, Gomez Guzman M, Galindo P, Haro J, Zarzuelo MJ, Boaretto S, Cogolludo A, Sanz MJ, Perez Vizcaino F, Duarte J
- PPARalpha agonist fenofibrate and PPARgamma agonist GW1929 differently regulate classical and alternative activation pathways in macrophages
Pekurinen A, Paukkeri EL, Moilanen E
- PPARgamma and PPARdelta agonists downregulate interleukin-1-stimulated inflammatory responses in human chondrocytes
Paukkeri EL, Hamalainen M, Moilanen T, Moilanen E
- Prediction of total knee replacement in a 6-month multicentre clinical trial with chondroitin sulphate in knee osteoarthritis: results from a 4-year observation
Raynauld JP, Martel Pelletier J, Dorais M, Abram F, Haraoui B, Choquette D, Morin F, Bessette L, Beaulieu A, Pelletier JP
